Purinski receptor (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Purinski receptor" in Serbian language version.
refsWebsite
Global rank
Serbian rank
6th place
5th place
low place
low place
1st place
1st place
adisonline.com
- Baker WL, White CM (1. 8. 2009). „Role of Prasugrel, a Novel P2Y12 Receptor Antagonist, in the Management of Acute Coronary Syndromes”. American Journal of Cardiovascular Drugs. 9 (4): 213—229.. Link text Архивирано на веб-сајту Wayback Machine (24. фебруар 2012)
archive.org
- Harden TK, Boyer JL, Nicholas RA (1995). „P2-purinergic receptors: subtype-associated signaling responses and structure”. Annual Review of Pharmacology and Toxicology. 35: 541—79. PMID 7598506. doi:10.1146/annurev.pa.35.040195.002545.
- Wang EC, Lee JM, Ruiz WG, Balestreire EM, von Bodungen M, Barrick S, Cockayne DA, Birder LA, Apodaca G (2005). „ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells”. The Journal of Clinical Investigation. 115 (9): 2412—22. PMC 1187935
. PMID 16110327. doi:10.1172/JCI24086.
doi.org
- Harden TK, Boyer JL, Nicholas RA (1995). „P2-purinergic receptors: subtype-associated signaling responses and structure”. Annual Review of Pharmacology and Toxicology. 35: 541—79. PMID 7598506. doi:10.1146/annurev.pa.35.040195.002545.
- Wang EC, Lee JM, Ruiz WG, Balestreire EM, von Bodungen M, Barrick S, Cockayne DA, Birder LA, Apodaca G (2005). „ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells”. The Journal of Clinical Investigation. 115 (9): 2412—22. PMC 1187935 . PMID 16110327. doi:10.1172/JCI24086.
- Savi, P; Zachayus, J. L.; et al. (2006). „The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts”. Proceedings of the National Academy of Sciences of the USA. 103 (29): 11069—11074. PMC 1635153 . PMID 16835302. doi:10.1073/pnas.0510446103.[мртва веза]
nih.gov
ncbi.nlm.nih.gov
- Harden TK, Boyer JL, Nicholas RA (1995). „P2-purinergic receptors: subtype-associated signaling responses and structure”. Annual Review of Pharmacology and Toxicology. 35: 541—79. PMID 7598506. doi:10.1146/annurev.pa.35.040195.002545.
- Wang EC, Lee JM, Ruiz WG, Balestreire EM, von Bodungen M, Barrick S, Cockayne DA, Birder LA, Apodaca G (2005). „ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells”. The Journal of Clinical Investigation. 115 (9): 2412—22. PMC 1187935 . PMID 16110327. doi:10.1172/JCI24086.
- Savi, P; Zachayus, J. L.; et al. (2006). „The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts”. Proceedings of the National Academy of Sciences of the USA. 103 (29): 11069—11074. PMC 1635153 . PMID 16835302. doi:10.1073/pnas.0510446103.[мртва веза]
pubmedcentral.nih.gov
- Savi, P; Zachayus, J. L.; et al. (2006). „The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts”. Proceedings of the National Academy of Sciences of the USA. 103 (29): 11069—11074. PMC 1635153 . PMID 16835302. doi:10.1073/pnas.0510446103.[мртва веза]
web.archive.org
- Baker WL, White CM (1. 8. 2009). „Role of Prasugrel, a Novel P2Y12 Receptor Antagonist, in the Management of Acute Coronary Syndromes”. American Journal of Cardiovascular Drugs. 9 (4): 213—229.. Link text Архивирано на веб-сајту Wayback Machine (24. фебруар 2012)